Marinya Capital
VC Fund
Sydney, Australia
Marinya Capital is a VC fund in Sydney focused on Biotechnology and Food and Beverage. Marinya Capital is the family office of a branch of the Fairfax family. It was originally established by Fairfax media, a large Australian media company. Marinya holds active property investments and a portfolio of investments into fund managers. Marinya Capital also makes direct private equity and venture capital investments into selectopportunities.
- Total investments:
- 11
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Marinya Capital invests in
Stages Marinya Capital invests in
Countries Marinya Capital invests in
Round sizes
Round size
- Seed
- $2.1M–$4.7M
- Series A
- $23M–$25M
Investment Focus
Industry
- Biotechnology 3 (27%)
- Food and Beverage 3 (27%)
- Alternative Protein 3 (27%)
- Aquaculture 2 (18%)
- Sustainability 2 (18%)
Stage
- Seed 4 (36%)
- Series A 2 (18%)
- Series B 2 (18%)
- Venture - Series Unknown 2 (18%)
- Series C 1 (9%)
Country
- United States 3 (27%)
- Australia 2 (18%)
- United Kingdom 2 (18%)
- Mexico 1 (9%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Unicorn Biotechnologies
|
Unicorn Biotechnologies has built the turing machine for biology that read and writes scientific endeavour in iterative loops automatically by combining state of the art hardware, software and machine learning approaches. | $3.2M / Seed / Apr 21, 2022 | |
New Culture
|
New Culture is a food and beverage company that focuses on revolutionizing how cheese is made. It was founded in 2018 and headquartered in San Francisco, California. | $25M / Series A / Nov 22, 2021 | |
microTERRA
|
Sustainable, scalable and affordable plant-based protein, grown in aquafarms, reducing waste water output for farms and allowing the uptake of more sustainable aquaculture methods. | $2.5M / Seed / Oct 31, 2021 | |
Cover Genius
|
Cover Genius provides an insurance distribution platform designed to protect the customers of e-commerce companies. Its products feature integrated end-to-end insurance and warranty capabilities and offer dynamic product recommendations and pricing optimization, while also undertaking the payment of a customer's claim in real-time, enablingcustomers to access increased protection against any uncertainty.The company was founded in 2014. | $72.8M / Series C / Sep 27, 2021 | |
NovoNutrients
|
NovoNutrients is working to turn waste CO2 into high-value, low-cost proteins and additives for food and feed by developing proprietary microbes and advanced gas fermentation systems. | $4.7M / Seed / Jul 29, 2021 | |
|
NovoNutrients
|
NovoNutrients is working to turn waste CO2 into high-value, low-cost proteins and additives for food and feed by developing proprietary microbes and advanced gas fermentation systems. | $4.7M / Venture - Series Unknown / Jul 29, 2021 | |
Multus
|
Multus Biotechnology is a global leader in cell culture media design, helping biomanufacturing companies shorten their time to market while improving supply chain security. By combining high-throughput robotic automation and ML, Multus revolutionizes cell culture media development - delivering breakthrough performance and efficiency that werepreviously unattainable.Multus’ experienced, multi-disciplinary team of scientists and engineers is redefining the future of biomanufacturing. Harnessing the power of biology, automation, and machine learning, we accelerate the creation of high-performance, resource-efficient cell culture media, empowering the global bioeconomy and enabling the next generation of essential therapies, food, and materials. | $2.1M / Seed / Jul 19, 2021 | |
v2food
|
v2food was founded with a clear mission: to nourish the world’s growing population by creating an alternative to meat, without compromising on flavour.As global meat consumption rises, the challenge isn't about eliminating animal meat, but making it better for the planet and just as delicious.Our plant protein products are packed withrich, mouth-watering flavours that prove you don't have to compromise on taste to make a positive impact. Join us on our journey to revolutionize the food system and enjoy delicious, plant protein meals that are better for you and the planet! | $50.3M / Series B / Oct 20, 2020 | |
Sendle
|
The first postal service was invented in 1516, not long before William Shakespeare was born. Almost 500 years later, nothing much has changed. To be or not to be (waiting at ye olde worlde post office), that is the question. We're pretty sure you’ve got better things to do.Sendle brings the postal service into the 21st century. No morequeues, wasted lunchtimes or closing time dashes. Sendle picks up and delivers parcels up to 10kg door-to-door, at Australia Post prices, usually cheaper. | $13.8M / Venture - Series Unknown / Aug 18, 2020 | |
|
v2food
|
v2food was founded with a clear mission: to nourish the world’s growing population by creating an alternative to meat, without compromising on flavour.As global meat consumption rises, the challenge isn't about eliminating animal meat, but making it better for the planet and just as delicious.Our plant protein products are packed withrich, mouth-watering flavours that prove you don't have to compromise on taste to make a positive impact. Join us on our journey to revolutionize the food system and enjoy delicious, plant protein meals that are better for you and the planet! | $22.9M / Series A / Nov 25, 2019 | |
| See all 11 investments → | |||
Co-Investors
SOSV
7 deals together
Alumni Ventures
2 deals together
e squared
2 deals together
Grantham Foundation
2 deals together
Happiness Capital
2 deals together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Marinya Capital invest in?
Marinya Capital invests primarily in Biotechnology, Food and Beverage and Alternative Protein startups, most often at Seed and Series A stage. Most of the 11 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Marinya Capital's check size?
Marinya Capital typically joins rounds of $2.1M–$4.7M at Seed and $23M–$25M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Marinya Capital participates in.
When did Marinya Capital last invest?
The most recent investment recorded for Marinya Capital closed in Apr 2022. Shizune tracks 11 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
